---

Posted on: 03/16/2012

New trial: Cellular Immunotherapy with Alloreactive CTL

An Open Study at UCLA Medical Center

for Recurrent WHO Grade III Gliomas 

Click HERE for details.  (A .pdf will open in new window)

 

---

Click HERE to return to brain tumor news headlines.